Compare AU
Compare DRUG vs. NDQ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Global Healthcare Currency Hedged ETF (DRUG) and the Betashares Nasdaq 100 ETF (NDQ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | NDQ | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 64 | 6,961 |
Median incremental investment | $882.72 | $993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,967.19 | $2,793.00 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
DRUG | NDQ | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | BetaShares Nasdaq 100 ETF (ASX: NDQ) seeks to track the performance of the NASDAQ 100 index before account fees, expenses and taxes. The index tracks 100 of the largest non-financial companies listed on the NASDAQ market. |
Top 3 holdings | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) | NASDAQ 100 E-MINI JUN25 (0 %) MICROSOFT CORP (8.56 %) NVIDIA CORP (8.36 %) |
Top 3 industries | Other (76.17 %) Communication Services (33.53 %) Health Care (23.66 %) | Information Technology (50.75 %) Consumer Discretionary (14.22 %) Communication Services (12.70 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (97.15 %) Netherlands (0.92 %) Brazil (0.69 %) |
Management fee | 0.57 % | 0.48 % |
Key Summary
DRUG | NDQ | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | NASDAQ 100 Index |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.48 % |
Price | $7.61 | $48.67 |
Size | $167.407 million | $6.226 billion |
10Y return | N/A | 386.21 % |
Annual distribution yield (5Y) | 1.89 % | 2.88 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 26/05/2015 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | NDQ | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 64 | 6,961 |
Median incremental investment | $882.72 | $993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,967.19 | $2,793.00 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
DRUG | NDQ | |
|---|---|---|
Pros |
| |
Cons |
|
DRUG | NDQ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |